Program Schedule

1252
Identifying and Management of HIV Drug Resistance

Session: Meet-the-Professor Session: Managing HIV Toxicity and Drug Resistance
Saturday, October 11, 2014: 7:00 AM
Room: The Pennsylvania Convention Center: 119-AB
Athe Tsibris, MD, MS, Division of Infectious Diseases, Brigham and Women's Hospital, Cambridge, MA

Athe Tsibris is a clinician and molecular virologist interested in the mechanisms and clinical implications of HIV-1 drug resistance. His work in the lab has focused on HIV-1 resistance to CCR5 antagonists and more generally on how HIV enters target cells. Currently, his lab focuses on basic and translational projects that investigate the relationship between HIV reservoirs in peripheral blood and tissue, specifically of the female genital tract, and novel approaches to eradicate latent HIV infection. Athe is an Assistant Professor of Medicine at Harvard Medical School and regularly attends on the inpatient ID services at Massachusetts General Hospital and Brigham and Women's Hospital. He is active in the ACTG where he serves as a member of the HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG).



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek